Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Amgen
AMGN
$212B
| $236M | 0.12% |
927,404
+297,130
| +47% | +$73.6M |
|
177
Acadia Pharmaceuticals
ACAD
$4.45B
| $235M | 0.12% |
5,706,104
+1,796,141
| +46% | +$77.6M |
|
|
VAR
178
DELISTED
Varian Medical Systems, Inc.
VAR
| $235M | 0.12% |
1,364,695
-786,484
| -37% | -$124M |
|
179
Sensient Technologies
SXT
$5.3B
| $234M | 0.12% |
4,050,841
+33,990
| +0.8% | +$1.87M |
|
|
MRSH
180
Marsh
MRSH
$91.7B
| $233M | 0.12% |
2,033,247
+24,106
| +1% | +$2.76M |
|
181
Take-Two Interactive
TTWO
$46.3B
| $231M | 0.12% |
1,401,141
+30,291
| +2% | +$4.92M |
|
182
Hilton Worldwide
HLT
$72.6B
| $231M | 0.12% |
2,707,988
-1,701,766
| -39% | -$142M |
|
183
Newmont
NEM
$96.4B
| $231M | 0.12% |
3,637,013
-249,200
| -6% | -$16.2M |
|
184
Advanced Micro Devices
AMD
$741B
| $229M | 0.12% |
2,797,737
+264,286
| +10% | +$19.6M |
|
|
INFO
185
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $226M | 0.12% |
2,881,909
-677,360
| -19% | -$53.9M |
|
186
Veeva Systems
VEEV
$32.7B
| $218M | 0.11% |
776,362
+22,170
| +3% | +$5.84M |
|
187
Verizon
VZ
$201B
| $218M | 0.11% |
3,663,078
-179,455
| -5% | -$10.4M |
|
188
Lowe's Companies
LOW
$122B
| $217M | 0.11% |
1,308,003
-154,719
| -11% | -$23.8M |
|
189
Tesla
TSLA
$1.21T
| $213M | 0.11% |
1,492,107
-178,203
| -11% | -$21M |
|
190
Apollo Global Management
APO
$71.9B
| $213M | 0.11% |
4,754,108
+92,091
| +2% | +$4.43M |
|
191
Clarivate
CLVT
$1.53B
| $211M | 0.11% |
6,802,256
-1,447,220
| -18% | -$39.2M |
|
192
Analog Devices
ADI
$178B
| $209M | 0.11% |
1,792,311
-296,903
| -14% | -$34.8M |
|
193
S&P Global
SPGI
$125B
| $208M | 0.11% |
578,138
-36,493
| -6% | -$12.9M |
|
194
Casey's General Stores
CASY
$31.7B
| $208M | 0.11% |
1,168,713
-44,837
| -4% | -$7.58M |
|
|
K
195
DELISTED
Kellanova
K
| $207M | 0.11% |
3,412,382
+910,542
| +36% | +$57.8M |
|
|
ATVI
196
DELISTED
Activision Blizzard
ATVI
| $202M | 0.11% |
2,493,745
+1,108,300
| +80% | +$89.9M |
|
197
DexCom
DXCM
$28.9B
| $201M | 0.11% |
1,953,692
+262,112
| +15% | +$27.4M |
|
|
XLRN
198
DELISTED
Acceleron Pharma
XLRN
| $201M | 0.1% |
+1,783,939
| New | +$178M |
|
199
Vaxcyte
PCVX
$7.88B
| $200M | 0.1% |
4,196,429
-529,363
| -11% | -$21.1M |
|
|
MGP
200
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $199M | 0.1% |
7,127,564
-204,115
| -3% | -$5.68M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.